PeptideStack
5.2kquestions
20kanswers
220users

How many freeze-thaw cycles will liraglutide at 2.5 mg/mL tolerate?

Asked 6 Jan 2026Modified 3 months agoViewed 10k times
16

The particulars: liraglutide · 2.5 mg/mL.

I want a method I can write down and repeat, not a rule of thumb.

I would rather over-engineer this than discover a problem later, within reason.

Concretely, what should I do, and how would I know afterwards whether I did it right?

freeze-thaw
freeze-thaw

What repeated freezing does to a peptide in solution: ice-crystal shear at the growing front, freeze-concentration of solutes, pH shifts as buffer…

57 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
liraglutide
liraglutide

A once-daily GLP-1 receptor agonist and the compound that established the class. Still relevant for its shorter half-life, its paediatric and…

235 questions
shareeditfollowflag
UM
askedunit_math6.2k156 Jan 2026
4Do you know the residual moisture? It predicts this better than any date does. – fib4_reader 10 months ago
add a comment

5 Answers

Accepted answer first, then by votes
38

Accepted answer

Nobody has published a cycle count, and at 2.5 mg/mL the concentration tells you what a wrong guess costs: a 0.1 mL aliquot holds 0.25 mg and every microlitre is 2.5 µg. Damage from freezing is not gradual attrition — it is concentrated at the phase transitions, where ice excludes solute and the unfrozen fraction climbs well above 2.5 mg/mL for as long as the transition lasts. Two slow cycles can therefore do more than four fast ones, which is why a cycle count is the wrong unit in the first place. The way to make the number one is to make it one: split at reconstitution into single-draw aliquots, label each with 2.5 mg/mL and the date, and never thaw a container you will refreeze.

The relevant physics is ice-front concentration: as water crystallises, everything dissolved is concentrated into the shrinking liquid phase, including buffer salts.

During freezing, solutes are excluded from the ice lattice and concentrate into the residual liquid. Local concentrations can rise many-fold, which promotes aggregation independently of temperature.

Degradation pathway by condition

PathwayDominant whenDetected by
DeamidationSolution, neutral to alkaline pHRP-HPLC, +1 Da on MS
OxidationLight, trace metals, peroxidesRP-HPLC, +16 Da on MS
HydrolysisSolution, extremes of pHRP-HPLC, fragment masses
AggregationAgitation, interfaces, high concentrationSEC, visual haze; often invisible on RP-HPLC
Freeze-concentration damageFreeze-thaw of buffered solutionSEC, loss of recovered content

Let a frozen vial reach room temperature before opening it. Opening a cold vial in humid air condenses water into the cake, which raises residual moisture and undoes what lyophilisation achieved.

Aliquoting to eliminate repeated cycles is standard laboratory practice for exactly this reason.

Dry powder tolerates cycles far better than solution does.

edited 3 May 2026 by h_pergande — added a caveat about sampling

shareimprove this answerflag
HP
answered · acceptedh_pergande71k15817 Apr 2026
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
31

The honest answer is that people worry about the freezer temperature and should worry about the number of cycles.

The mitigation is aliquoting. Divide the reconstituted solution into single-use volumes before the first freeze, and each aliquot then experiences exactly one cycle.

Thaw slowly at room temperature or in the refrigerator rather than in warm water. Rapid warming creates local thermal and concentration gradients that promote aggregation.

The caveat is that aggregation is invisible in a clear solution below the threshold where it becomes visible.

Let a frozen vial reach room temperature before opening, or you condense water into it.

shareimprove this answerflag
C8
answeredcoldpack_8850k3728 Apr 2026
14

Specifically, this is one of the few handling questions with a genuinely quantitative literature behind it.

Never refreeze a thawed aliquot. The whole point of aliquoting is that the aliquot is single-use, and refreezing it discards the benefit.

In practice, buffer salts crystallise at different points during freezing. Sodium phosphate is the classic example: the dibasic form crystallises first and the pH of the residual liquid falls by several units. That pH excursion is the real damage in many cases.

Aliquot before the first freeze. That is the whole answer.

shareimprove this answerflag
DB
answeredDr_Fatima_Belkacem18k266 Apr 2026
12

Buffer components crystallise at different rates during freezing, which shifts pH locally by a surprising amount.

A dry lyophilised powder is much less affected by a temperature cycle because there is no liquid phase for anything to concentrate into. Condensation on a cold vial opened warm is the real risk there.

Count cycles, not degrees. The cycle is the damaging event.

shareimprove this answerflag
PS
answeredplunger_stop13k2726 Mar 2026
2The desiccant point is under-appreciated and costs nothing to act on. – ben_akintola 5 months ago
3Adding for future readers: the domestic leg after delivery is the part you control. – tess_amankwah 7 months ago
add a comment
9

Answer first: each freeze-thaw cycle costs something through aggregation and pH shift, so the mitigation is aliquoting rather than choosing a better freezer.

Count cycles rather than worrying about degrees. Minus twenty and minus eighty differ far less than one cycle and five do.

Aliquoting itself is a handling step and introduces its own contamination opportunity.

Thaw slowly and never refreeze an aliquot.

shareimprove this answerflag
LB
answeredliam_bracken6.9k1412 Feb 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.